SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN)
| CAPS Rating |
|
|---|---|
| Open | $5.06 |
| Previous Close | $5.10 |
| Daily Range | $5.06 - $5.15 |
| 52-Week Range | $3.30 - $6.88 |
| Market Cap | $297.44M |
| P/E Ratio | 11.30 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 92,372 |
| Average Daily Volume | 0 |
SCLN
VS S&P 500 (SPY)
How do you think SCLN will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
SCLN Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
SCLN News and Commentary
- Avoid This Biotech Stock – The Motley Fool
- The Highest-Rated Biopharma Stocks – The Motley Fool
- Insomnia Found to Cost $63 Billion a Year - Here are 4 Companies to Treat It – NASDAQ
- Trading Plan for July 15, 2011 – Blog at The Motley Fool
- 24 Proven Growth Companies at Potential Bargains – SeekingAlpha
- My Flexible Mini-Micro Stock Selection Model – SeekingAlpha
- 5 Stocks That Might Not Be Trading Under $5 Much Longer – SeekingAlpha
- The Fool Looks Ahead – The Motley Fool
- 10 Small Cap Stocks With Positive Earnings Surprises – SeekingAlpha
- 19 High Growth Micro Cap Stocks Under $10 – SeekingAlpha
- Amass Your Fortune With These Stocks – The Motley Fool
- 7 Biotech Penny Stocks to Buy – NASDAQ
- 10 Small Cap Stocks With Positive Earnings Surprises – SeekingAlpha
- BEFORE THE BELL -2: US HOT STOCKS TO WATCH – SmartMoney
- Amgen, Celgene and Novartis in the Fight Against Pancreatic Cancer – SeekingAlpha
- Healthcare Headlines: Santarus Rallies, Amgen Announces Results – SeekingAlpha
- Amass Your Fortune With These Top Stocks – The Motley Fool
- Merck, SciClone Tapped in Fed Pharma Probe – SeekingAlpha
- 10 Small Cap Earnings Growers – SeekingAlpha
- Dream Stocks for Biotech Investors – The Motley Fool
RSS Headlines
Fool UK
